Published in Blood Weekly, December 4th, 2003
In the journal Bone Marrow Transplantation, hematologists in Switzerland described the "graft product stem cell yields and donor safety results of a randomized multicenter study comparing allogeneic peripheral blood stem cell (PBSC) transplantation with bone marrow (BM) transplantation."
"Matched HLA-identical sibling donors (n=329) were randomized to filgrastim-mobilized PBSC or BM donation groups," explained G. Gavre and coauthors working at Kantonsspital Basel.
"Median yields per kg recipient weight of CD34+ cells, T cells, and natural killer (NK) cells,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.